MVF.AU · Monash IVF Group Limited

-

Please sign in to comment on MVF.AU

1 Comment

Admin

3 years, 7 months ago

Monash IVF Group Limited is currently in a long term uptrend where the price is trading 8.3% above its 200 day moving average.

From a valuation standpoint, the stock is 99.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.1.

Monash IVF Group Limited's total revenue rose by 17.8% to $91M since the same quarter in the previous year.

Its net income has increased by 78.5% to $15M since the same quarter in the previous year.

Finally, its free cash flow grew by 335.7% to $7M since the same quarter in the previous year.

Based on the above factors, Monash IVF Group Limited gets an overall score of 5/5.

CurrencyCode	AUD
Exchange	AU
Industry	Diagnostics & Research
Sector	Healthcare
ISIN	AU000000MVF3

PE Ratio	25.35
Dividend Yield	4.0%
Target Price	1.31
Beta	1.59
Market Cap	425M

ABOUT

Monash IVF Group Limited

Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic and IVF treatment services. The company was incorporated in 2014 and is based in Richmond, Australia.

MVF.AU · Monash IVF Group Limited

-

Monash IVF Group Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Monash IVF Group Limited using a moving average strategy